NCH Continues its Expansion of Cancer Program with New Specialists and Services - Coastal Breeze News
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
Naples Comprehensive Health (NCH) is expanding its cancer program through the recruitment of specialized physicians, the addition of new clinical services and the continued expansion of an integrated model of care designed to provide patients with comprehensive cancer treatment close to home. Led by Javier Muñoz, MD, Cancer Center Director, the program is bringing together experts across medical, cardiac and surgical oncology, pulmonary medicine, imaging, pathology and supportive care to deliver coordinated, patient-centered cancer care. “When 35% of cancer patients leave Southwest Florida to receive care, it signals a significant unmet need in our region,” said Paul Hiltz, President and CEO of NCH. “That’s why we’re enhancing this integrated program around the needs of each patient, bringing together highly specialized physicians, advanced diagnostic and treatment capabilities, clinical research and the expertise of Northwestern Medicine so more patients can receive sophisticated, coordinated cancer care here in Southwest Florida.”As part of its continued growth, NCH will be hiring a breast medical oncologist in January.
This article is an excerpt. To read the full content, visit the original source. Coastal Breeze News
Related articles
Precision Healthcare Specialists adds endocrinology services in Lee, Charlotte counties - Florida Hospital News and Healthcare Report
Bioengineer.org | Viral blips during HIV therapy are common and rarely signal treatment failure, Swedish study finds - European AIDS Treatment Group
Bioengineer.org news storyFor people living with HIV, modern antiretroviral therapy can suppress the virus to levels below what standard laboratory tests can detect. Yet some patients on long-term treatment experience a curious phenomenon: a single test result showing a small, transient amount of virus in the blood, followed by an immediate return to undetectable levels. These events, known as viral blips, have puzzled clinicians and researchers for years, raising questions about whether they represent harmless statistical noise, brief bursts of viral production from hidden reservoirs, or early warnings of impending treatment failure. A new nationwide Swedish study, published in BMC Infectious Diseases, offers one of the most comprehensive answers to date. Drawing on the Swedish national InfCareHIV cohort, researchers analyzed data from 4,210 treatment-naïve adults who began antiretroviral therapy from 1 January 2007 onward, with follow-up data extracted through 30 September 2020. The median observation time was 5.5 years, with some individuals followed for as long as 13.7 years.
European Medical Journal | HIV linked to early signs of heart dysfunction - European AIDS Treatment Group
European Medical Journal news storyPeople living with HIV may experience subtle changes in heart muscle function even when conventional measures of cardiac performance remain normal, according to findings from a systematic review and meta-analysis. Researchers identified significantly impaired global longitudinal strain (GLS) among people with HIV compared with HIV-uninfected individuals, despite preserved left ventricular ejection fraction (LVEF) in both groups. The findings suggest that speckle-tracking echocardiography (STE) could provide additional information about early myocardial dysfunction in this population. Read the full news story here.
Patient-centered financial navigation assistance helps reduce financial toxicity among cancer patients - Medical Xpress
Among cancer patients, the high financial cost of cancer care is a prevalent problem. This financial burden is also associated with potentially harmful behavioral strategies that patients might use to cope with costs, such as delaying or forgoing treatment and skipping medications. Collectively, researchers refer to this impact as financial toxicity.
0 comments
No comments yet. Be the first to share your thoughts!